Jacqueline Barrientos

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    AstraZeneca
    Topic:
    Advisory Board
    Date added:
    09/11/2023
    Date updated:
    09/11/2023
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Beigene
    Topic:
    Advisory Board
    Date added:
    09/11/2023
    Date updated:
    09/11/2023
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Pharmacyclics
    Topic:
    Advisory Board
    Date added:
    09/11/2023
    Date updated:
    09/11/2023
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Merck
    Topic:
    advisory board, research
    Date added:
    09/11/2023
    Date updated:
    09/11/2023
Return to 2023 Annual Summit on Hematologic Cancers: Incorporation of Novel Therapies in Clinical Practice